These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19699233)
1. Viral vector approaches to modify gene expression in the brain. Papale A; Cerovic M; Brambilla R J Neurosci Methods; 2009 Dec; 185(1):1-14. PubMed ID: 19699233 [TBL] [Abstract][Full Text] [Related]
2. Progress and challenges in viral vector-mediated gene transfer to the brain. Lowenstein PR; Castro MG Curr Opin Mol Ther; 2002 Aug; 4(4):359-71. PubMed ID: 12222874 [TBL] [Abstract][Full Text] [Related]
3. Hybrid vector designs to control the delivery, fate and expression of transgenes. Lam PY; Breakefield XO J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260 [TBL] [Abstract][Full Text] [Related]
4. Viral vectors as part of an integrated functional genomics program. Janson CG; During MJ Genomics; 2001 Nov; 78(1-2):3-6. PubMed ID: 11707065 [TBL] [Abstract][Full Text] [Related]
5. Viral vector-mediated gene transfer for CNS disease. Snyder BR; Boulis NM; Federici T Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059 [TBL] [Abstract][Full Text] [Related]
6. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619 [TBL] [Abstract][Full Text] [Related]
7. Vectors and delivery systems in gene therapy. Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707 [TBL] [Abstract][Full Text] [Related]
8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
9. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Douglas KL Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953 [TBL] [Abstract][Full Text] [Related]
10. Gene manipulation with stereotaxic viral infection for psychiatric research: spatiotemporal components for schizophrenia. Seshadri AJ; Hayashi-Takagi A Prog Brain Res; 2009; 179():17-27. PubMed ID: 20302814 [TBL] [Abstract][Full Text] [Related]
11. Viral vectors as tools to model and treat neurodegenerative disorders. Déglon N; Hantraye P J Gene Med; 2005 May; 7(5):530-9. PubMed ID: 15651039 [TBL] [Abstract][Full Text] [Related]
12. Viral vectors for gene delivery to the nervous system. Davidson BL; Breakefield XO Nat Rev Neurosci; 2003 May; 4(5):353-64. PubMed ID: 12728263 [No Abstract] [Full Text] [Related]
13. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Romano G; Michell P; Pacilio C; Giordano A Stem Cells; 2000; 18(1):19-39. PubMed ID: 10661569 [TBL] [Abstract][Full Text] [Related]
15. [Vectors of gene transfer. Applications in pneumology]. Demoly P; Mathieu M; Pujol JL; Bousquet J; Godard P; Michel FB Rev Mal Respir; 1996 Jul; 13(3):251-7. PubMed ID: 8765917 [TBL] [Abstract][Full Text] [Related]
16. Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function. Teschemacher AG; Wang S; Lonergan T; Duale H; Waki H; Paton JF; Kasparov S Exp Physiol; 2005 Jan; 90(1):61-9. PubMed ID: 15542618 [TBL] [Abstract][Full Text] [Related]
17. Viral and non-viral methods for gene transfer into skeletal muscle. Wells DJ Curr Opin Drug Discov Devel; 2006 Mar; 9(2):163-8. PubMed ID: 16566286 [TBL] [Abstract][Full Text] [Related]